| Literature DB >> 34770804 |
Shamsher Ali1, Eric Hénon2, Ritchy Leroy2, Georges Massiot2.
Abstract
Vindoline and catharanthine are the major alkaloids of Catharanthus roseus and are extracted in large quantities to prepare the pharmaceutically important Vinca type alkaloids vincaleukoblastine, vincristine and navelbine. The higher yield of vindoline relative to catharanthine makes it an attractive substrate for developing new chemistry and adding value to the plant. In this context, we have reacted vindoline with a selection of electrophiles among which benzoquinone. Conditions were developed to optimize the synthesis of a mono-adduct, of five bis-adducts, and of tri-adducts and tetra-adducts, several of these adducts being mixtures of conformational isomers. Copper(II) was added to the reactions to promote reoxidation of the intermediate hydroquinones and simplify the reaction products. The structures were solved by spectroscopic means and by symmetry considerations. Among the bis-isomers, the 2,3-diadduct consists of three unseparable species, two major ones with an axis of symmetry, thus giving a single set of signals and existing as two different species with indistinguishable NMR spectra. The third and minor isomer has no symmetry and therefore exhibits nonequivalence in the signals of the two vindoline moieties. These isomers are designated as syn (minor) and anti (major) and there exists a high energy barrier between them making their interconversion difficult. DFT calculations on simplified model compounds demonstrate that the syn-anti interconversion is not possible at room temperature on the NMR chemical shift time scale. These molecules are not rigid and calculations showed a back-and-forth conrotatory motion of the two vindolines. This "windshield wiper" effect is responsible for the observation of exchange correlations in the NOESY spectra. The same phenomenon is observed with the higher molecular weight adducts, which are also mixtures of rotational isomers. The same lack of rotations between syn and anti isomers is responsible for the formation of four tri-adducts and of seven tetra-adducts. On a biological standpoint, the mono adduct displayed anti-inflammatory properties at the 5 μM level while the di-adducts and tri-adducts showed moderate cytotoxicity against Au565, and HeLa cancer cell lines.Entities:
Keywords: atropoisomerism; benzoquinone; cytotoxicity; vindoline
Mesh:
Substances:
Year: 2021 PMID: 34770804 PMCID: PMC8587549 DOI: 10.3390/molecules26216395
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1The addition of nucleophiles to benzoquinone (BQ = benzoquinone, Ox is an oxidant).
Products obtained with vindoline 1 addition to benzoquinone 2. Reaction conditions: all reactions were performed on 200 mg 1 (0.44 mmol) except entries 1, 2 (20 mg) and 9–11, 13, 14 (150 mg); catalyst (CuCl2): entries 1–8: none, entries 9, 10: 0.6 mmol, entries 11, 12: 6.6 mmol, entries 13, 14: 3.3 mmol. Reaction time was 24 h, except 10, 12 (8 h) and 13, 14 (48 h). TFA (1 mL) was added in reactions 6–14 and 0.3 mL in entries 4, 5. Solvent was MeOH (entries 1, 2), CH3CN:H2O 7:1 (entries 3, 9) or CH3CN:H2O 1:2 (entries 10–14).
| Entry | 1 | 2 | Yield (%) | |||||
|---|---|---|---|---|---|---|---|---|
| Mole Ratio | 3 | 4 | 5 | 6 | 7 | 8 | ||
| 1 | 1 | 1 | NR | |||||
| 2 | 1 | 1 | NR | |||||
| 3 | 1 | 1 | 48 | 3 | 16 | |||
| 4 | 1 | 1 | 24 | 2 | 20 | |||
| 5 | 2 | 1 | 14 | 2 | 15 | |||
| 6 | 1 | 1 | 38 | 4 | 36 | |||
| 7 | 1 | 2 | 71 | 2 | 20 | |||
| 8 | 1 | 4 | 95 | 3 | ||||
| 9 | 2 | 1 | 16 | 4 | 40 | |||
| 10 | 2 | 1 | 12 | 5 | 59 | 5 | ||
| 11 | 2 | 1 | 23 | 5.5 | 32 | 4 | traces | |
| 12 | 2.4 | 1 | traces | 8 | 75 | 7 | ||
| 13 | 3 | 1 | 2 | 34 | traces | 31 | 4 | |
| 14 | 4 | 1 | 5 | 37 | 15 | |||
Scheme 2Formation of the mono-adduct of vindoline and benzoquinone.
Scheme 3The preparation of poly-adducts of vindoline and benzoquinone.
Figure 1The three bis adducts of vindoline (V) and benzoquinone.
Figure 2Structures and molecular models for compounds 6a and 6b.
Figure 3A simplified representation of compounds 6a1, 6a2 and 6b.
Figure 4The four possible tri-adducts 7a1, 7a2, 7b and 7c.
Figure 5High field part of the 1H NMR spectrum of the mixture of tri-adducts showing similar intensities for three CH3-18 in the major isomer.
Figure 6Tetra-adducts with three vindolines with same orientation.
Figure 7Tetra-adducts with two vindolines with same orientation.
Scheme 4Vindoline exchanges by rotations around axes xx’ and yy’ in 8a.
Figure 8NOESY correlations between methyl groups in compounds 6.
Scheme 5Sequence of events leading to tetra-adducts.
Cytotoxicity of compounds 3, 4, 5 and 7 against HeLa, Au565 cancer, and 3T3 normal cell lines.
| Test | HeLa | Au 565 | 3T3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Compounds | Conc. | % Inhibition | IC50 ± SD | Conc. | % Inhibition | IC50 ± SD | Conc. (µM) | % Inhibition | IC50 ± SD |
| (µM) | (µM) | (µM) | (µM) | (µM) | |||||
|
| 30 | 10.1 | Inactive | 50 | Inactive | 50 | 40.2 | Inactive | |
|
| 30 | 96.2 | 12 ± 2 | 50 | 98.39 | 6 ± 0.2 | 50 | 93.9 | 4 ± 0 |
|
| 30 | 99.2 | 4 ± 0.6 | 50 | 98.83 | 2 ± 0.2 | 50 | 99.6 | 6 ± 0.2 |
|
| 30 | 86.14 | 14 ± 2 | 50 | 85.73 | 7 ± 1 | 50 | 84.0 | 21 ± 1 |
| Doxorubicin | 30 | 89.1 | 1.3 ± 04 | 50 | 98.77 | 0.085 ± 0.03 | - | - | - |
| Cycloheximide | - | - | - | - | - | - | - | - | 0.26 ± 0.1 |